## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 


## 

## 





## 

## 

## 



## 

||||Unrestricted|Restricted|||
|---|---|---|---|---|---|---|
||||funds|funds|||
||||||Total|Total|
|||Notes|||2022|2021|
|Income and|endowments|from:|||||
|Charitable|Activities|||55,725|55,725|15,850|
|Income f'rom investments||||7|7|495|
|Total||||55,732|SS,732|16,34S|
|Kxpenditure|on:||||||
|Charitable|Activities||||||
|GP Tutor||||9,642|9,642|12,724|
|Clinical tutor|||3S1|16,725|17,076|2,876|
|Climcal tutor MRCP||||120|120|3,600|
|UTS||||1,397|1,397|100|
|Surgical Tutor||||11,429|11,429|1,163|
|ARE||||944|944|500|
|Histopathology||||520|520||
|Council||||20|20||
|Total|||351|40,797|41,148|20,963|
|Net incomel|(expenditure)||(351)|14,935|14,584|(4,6183|
|Funds at 1st|April 20?1brought forward||7|162,239|162,246|166,864|
|Funds at31stMarch 2022 carried forward|||(344)|177,174|176,830|162,246|





## 

## 





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 


## 



## 

## 

||||||||Clinincal|Clinincal|Clinincsl||Surgical|A8cE||Council|Histo-|Total||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||GP Tutor||Tutor||Tutor||Tutor||||pathology|||
||||||||||MRCP|||||||2022||
||||||||||8|||||||8||
||Sponsorship||||||||||3,500|||||3,500||
||Fees~g Sets<br>ATLS||||||17,825||8,100|6,000|20,300|||||26,300<br>25,925||
||||||||17,825||8,100|6,000|23,800|||||55,725||
||||||||Clmmcsl||Chmncal|VTS|Surgical|||Council|Histo-|Total||
||||||GP Tutor||Tutor||Tutor||Tutor||||pathology|||
||||||||||MRCP|||||||ZOll||
||||||||||8|||||||||
||Sponsorship|||||||250|100|||||||350||
||Fees||||||||3,500|12,000||||||15,500||
||Learning Sets|||||||||||||||||
||ATLS|||||||||||||||||
|||||||||250|3,600|12,000||||||15,850||
|4,|Expenditure||on Charitable|||acttvtttes||||||||||||
||||||||Clinincal||Clinincal|VTS|Surgical|AtkE||Council|Histo-|Total|Total|
||||||GP Tutor||Tutor||Tutor||Tutor||||pathology|||
|||||||||||||||||2022|2021|
||||||||g|||||||||||
||Depreciation|||||||351||||||||351|431|
||Repairs and rentals|||||||130||||||||130||
||Catering|||||399|2,625||||4,760||424|||8,208|32|
||Speakers|||||8,450||82||888||||||9,420|7,954|
||Room hire|||||174|||||875|||||1,049|350|
||Computer|equipment|||||||||||||||312|
||ATLS||||||11,502|||||||||11,502||
||Courses «nd||staA training|||70||35|||5,272|||||5,377|7,623|
||Simulation|||||||||||||||||
||Bank charges|||||||33|20|21|||20|20||179||
||Stationary|||||||71||||||||71||
||Promotional||expenses|||||||||||||||
||Miscellaneous||||||1,071|||288||||||1,385|985|
|||||||9,142|15,900||20|1,197|10,929||444|20|20|37,672|17,687|
||Share ofgovernance|||costs||500|1,1'76||100|200|SOO||500|-|SOO|3,476|3,276|
|||||||9,642|17|076|120|1,397|11,429||944|20|520|41,148|20,963|
||Analysis|by|fund current||year|||||||||||||
||Umestricted||funds|||||351||||||||351||
||Restricted|funds||||9,642|16,725||120|1,397|11,429||944|20|520|40,797||
|||||||9,642|1?076||120|1,397|11,429||944|20|520|41,148||
||Analysis|by|fund previous|||year||||||||||||
||Unrestricted||funds|||||431||||||||431||
||Restricted|funds||||12,724|2,445||3,600|100|1,163||500|||20,532||
|||||||12,724|2,876||3,600|100|1,163||500|||||





## 


|Support Costs|Support Costs||Total|Total|
|---|---|---|---|---|
||||20?2|2021|
|Independent|examiners|fee|3,476|3,276|



## 

|8,|Tangible fixed assets|Tangible fixed assets|Fixtures|Computers|Total|
|---|---|---|---|---|---|
||||and fitting|||
||Cost|||||
||At 1stApril 2021||2,509|9,927|12,436|
||Additions|||||
||At 31stMarch 2022||2,509|9,927|12,436|
||Depreciation<br>and impairment|||||
||At 1stApril 2021||1,911|8,623|10,534|
||Depreciation<br>charged|in the year|90|261|351|
||At 31stMarch 2022||2,001|8,884|10,885|
||Carrying<br>amount|||||
||At 31stMarch 2022||508|1,043|1,551|
||At 31stMarch 2021||598|1,304|1,902|
|9.|Debtors|||2022|2021|
||Amounts<br>falling due within one year:|||||
||Other debtors|||4,222|1,126|
|10.|Creditors: amount|falling due within one year||20?2|2021|
||Accruals and deferred income|||3,440|11,340|





## 

## 

## 

|Movement in Funds|- current year||||||
|---|---|---|---|---|---|---|
||Balances|Incoming|Investment|Transfers|Resources|Balances|
||1.4.2021|resources|income||expended|31,3,2022|
|GP Tutor|22,S73||||9,642|12,931|
|Clinical tutor|51,364|17,825|||16,725|52,471|
|Barron Fund|27,624|||||27,624|
|General Fund|115|||||115|
|Clinical tutor MRCP|394|8,100|||120|8,374|
|UTS|16,931|6,000|||1,397|21,534|
|Surgical Tutor|35,008|23,800|||11,429|47,379|
|ARE|5,860||||944|4,916|
|Council|||||20|(20)|
|Histopathology|2,370||||520|1,850|
||162,239|55,725|||40,797|177,174|
|Movement<br>in Funds|- previous year||||||
||Balances|Incoming|Investment|Transfers|Resources|Balances|
||1.4.2020|resources|income||expended|31,3.2021|
|GP Tutor|35,297||||12,724|22,573|
|Clinical tutor|53,064|250|495||2,445|51,364|
|Barron Fund|27,624|||||27,624|
|General Fund|115|||||115|
|Clinical tutor MRCP|394|3,600|||3,600|394|
|VTS|5,031|12,000|||100|16,931|
|Surgical Tutor|36,171||||1,163|35,008|
|ARE|6,360||||500|5,860|
|Histopathology|2,370|||||2,370|
||166,426|15,850|495||20,532|162,239|